abstract |
The present invention relates to a combination composition, characterized by comprising particles containing vildagliptin or a pharmaceutically acceptable salt or polymorph of vildagliptin, and particles containing gliclazide or a pharmaceutically acceptable salt or polymorph of gliclazide. |